Cascadian Therapeutics Inc. buy stratec
Start price
30.01.18
/
50%
€5.07
Target price
13.04.18
€9.66
Performance (%)
78.29%
End price
13.04.18
€9.04
Summary
This prediction ended on 13.04.18 with a price of €9.04. The BUY prediction by stratec for Cascadian Therapeutics Inc. saw massive gains of 78.29%. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cascadian Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | -0.531% | 3.824% | 15.862% | 16.424% |
iShares Nasdaq 100 | 2.338% | 3.067% | 21.901% | 35.414% |
iShares Nikkei 225® | 1.332% | 5.933% | 12.099% | -0.322% |
iShares S&P 500 | 1.181% | 3.042% | 22.103% | 38.834% |
Comments by stratec for this prediction
In the thread Cascadian Therapeutics Inc. diskutieren
Cascadian Therapeutics is a Conviction Buy
31.01.2017
- Seattle Genetics (NASDAQ:SGEN) has agreed to acquire Cascadian Therapeutics (NYSE:CASC) for $10 per share in cash, more than a 69% premium to yesterday's closing price of $5.90. Total consideration will be ~$614M.
(Vom Mitglied beendet)